Annabelle Ayame Okada
8PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 10, 2025
A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning.Matthias Gutfleisch, Britta Heimes-Bussmann, Sökmen Aydin
|Mar 14, 2024
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial.Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa
|Nov 11, 2022
Automated Quantitative Analysis of Anterior Segment Inflammation Using Swept-Source Anterior Segment Optical Coherence Tomography: A Pilot Study.Hiroshi Keino, Takuto Aman, Ryota Furuya
|May 03, 2022
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup.Annabelle A Okada, Kanji Takahashi, Masahito Ohji
|Feb 02, 2021
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.Jean-François Korobelnik, Anat Loewenstein, Bora Eldem
|Mar 02, 2019
Epidemiology of Macular Edema in Uveitis.Massimo Accorinti, Annabelle A Okada, Justine R Smith
Pageof 2
Frequent Collaborators
1 joint publications
Massimo Accorinti
1 joint publications
Justine R Smith
1 joint publications
Marta Gilardi
1 joint publications
Jean-François Korobelnik
1 joint publications
Paolo Lanzetta
1 joint publications
Francisco J Rodríguez
1 joint publications
Lihteh Wu
1 joint publications
Yuji Hatanaka
1 joint publications
Matthias Gutfleisch
1 joint publications
Britta Heimes-Bussmann
